Joe McKendrick

2.6k citations
9 papers · 1.1k indexed · 1 hit paper · h-index 7
Topics
Cancer Treatment and Pharmacology (3 papers)Testicular diseases and treatments (2 papers)Colorectal Cancer Treatments and Studies (2 papers)

In The Last Decade

Joe McKendrick

9 papers receiving 1.1k citations

Hit Papers

Addition of Aflibercept to Fluorouracil, Leucovorin, and ...20122026201620212012250500750

Peers

Joe McKendrick
Comparison fields: 5 of 63
  • Oncology 865
  • Pulmonary and Respiratory Medicine 420
  • Hepatology 292
  • Molecular Biology 219
  • Pathology and Forensic Medicine 176
Replace Federico Nasroulah with:
Federico Nasroulah United States
B. Nelson United States
Eugenio Marcuello Spain
Nikolaos Ziras Greece
Silvia Mezi Italy
T Buroker United States
M. Machiavelli Argentina
M. Morse United States
Stefano Cereda Italy
Niek Hugen Netherlands
Joe McKendrick relative to Federico Nasroulah United States Federico Nasroulah's profile →
Citations per field
00.5×1.5×
Federico Nasroulah · 1×
Citations per year

Countries citing papers authored by Joe McKendrick

Since Specialization
Citations

This map shows the geographic impact of Joe McKendrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joe McKendrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joe McKendrick more than expected).

Fields of papers citing papers by Joe McKendrick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joe McKendrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joe McKendrick. The network helps show where Joe McKendrick may publish in the future.

Co-authorship network of co-authors of Joe McKendrick

This figure shows the co-authorship network connecting the top 25 collaborators of Joe McKendrick. A scholar is included among the top collaborators of Joe McKendrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joe McKendrick. Joe McKendrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 11
2
Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimenbreakdown →
986
3 14
4
Metastatic urachal cancer responding to FOLFOX chemotherapy.
29
5 4
6 4
7 23
8 28
9 20

About Joe McKendrick

Joe McKendrick is a scholar working on Occupational Therapy, Oncology and Neurology, having authored 9 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), Testicular diseases and treatments (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Hepatology (292 citations), Oncology (865 citations) and Pulmonary and Respiratory Medicine (420 citations). Joe McKendrick has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include David Ferry, Radek Lakomý, Teresa Macarulla, Vladimir Moiseyenko, Carmen J. Allegra, Guy A. Van Hazel, Eric Van Cutsem, R Castan, Jana Prausová and Paul Ruff. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026